Human IgG Quick test strip |
|||
E411A02-10 | EnoGene | 10 tests | EUR 150 |
Human IgG antibody Laboratories manufactures the antibody test sarscov2 reagents distributed by Genprice. The Antibody Test Sarscov2 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Test Group: Sarscov2
Mouse IgG Quick test strip |
||
EnoGene | 10 tests | EUR 150 |
True Blue |
||
MedKoo Biosciences | 5.0mg | EUR 595 |
True Blue |
||
TargetMol Chemicals | 10mg | Ask for price |
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 1g | Ask for price |
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 1mg | Ask for price |
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 50mg | Ask for price |
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 5mg | Ask for price |
Description: True Blue |
SARS-CoV-2 Spike Antibody |
|||
10-2869 | Fitzgerald | 1 mg | EUR 1000 |
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
|||
10-2870 | Fitzgerald | 1 mg | EUR 1000 |
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
|||
10-2871 | Fitzgerald | 1 mg | EUR 1000 |
Description: SARS-CoV-2 Spike Antibody, Recombinant Human |
SARS-CoV-2 Spike Antibody |
|||
10-2906 | Fitzgerald | 1 mg | EUR 225 |
Description: Anti-SARS-CoV-2 Spike Protein Monoclonal antibody |
SARS-CoV-2 Spike Antibody |
|||
10-2907 | Fitzgerald | 1 mg | EUR 225 |
Description: Anti-SARS-CoV-2 Spike Protein Monoclonal antibody |
SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb |
|||
BSV-COV-AB-09 | BioServUK | 50 ul | Ask for price |
Description: SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb (Spike (S1), Monoclonal) |
SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb |
|||
BSV-COV-AB-10 | BioServUK | 100 ul | Ask for price |
Description: SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb (Spike (S1), Monoclonal) |
SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit MAb |
|||
21804 | SAB | 100ul | EUR 1039 |
Mouse Anti SARS-CoV-2 Spike (S2) Antibody (0018) |
|||
MAB12421-50 | The Native Antigen Company | 0.05 | EUR 588.13 |
Description: Mouse monoclonal antibody against SARS-CoV-2 glycoprotein Spike S2. |
Anti-Spike S1 Antibody (SARS-CoV-2) |
|||
100715-1 | BPS Bioscience | 20 µg | EUR 300 |
Description: Recombinant human monoclonal antibody recognizing the SARS-CoV-2 Spike RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus. |
Anti-Spike S1 Antibody (SARS-CoV-2) |
|||
100715-2 | BPS Bioscience | 100 µg | EUR 440 |
Description: Recombinant human monoclonal antibody recognizing the SARS-CoV-2 Spike RBD glycoprotein. This antibody cross-reacts with the Spike protein from the SARS-CoV virus. |
SARS-CoV-2 Spike RBD Antibody Pair 1 |
|||
55R-2273 | Fitzgerald | 1 set | EUR 833 |
Description: SARS-CoV-2 Spike RBD Antibody Pair 1 |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
9155-002mg | ProSci | 0.02 mg | EUR 229.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) NSP7 Antibody |
|||
9155-01mg | ProSci | 0.1 mg | EUR 594.26 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers. |
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9159-002mg | ProSci | 0.02 mg | EUR 229.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
SARS-CoV-2 (COVID-19) NSP8 Antibody |
|||
9159-01mg | ProSci | 0.1 mg | EUR 594.26 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6). |
SARS-CoV-2 (COVID-19) NSP9 Antibody |
|||
9161-002mg | ProSci | 0.02 mg | EUR 229.7 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP9 may participate in viral replication by acting as a ssRNA-binding protein (3). |